Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial

Table 5

Patients' symptom scores on the EORTC QLQ-C30.

Symptom scales	Experimental group (𝑛=25)	Control group (𝑛=23)
Fatigue
Week 0	43.7±17.9	42.3±15.7
Week 4	31.1±18.1^**##	40.2±16.8
Pain
Week 0	32.4±12.7	31.3±13.6
Week 4	29.3±14.6	30.7±17.3
Sleep disturbance
Week 0	56.5±21.8	55.8±22.6
Week 4	42.3±26.2^**##	53.9±24.8
Appetite loss
Week 0	32.5±19.3	32.3±17.4
Week 4	24.3±18.4^*#	30.3±16.5
Constipation
Week 0	31.1±11.4	32.5±12.8
Week 4	28.2±13.3	30.6±14.7
Diarrhea
Week 0	12.9±10.9	12.7±10.5
Week 4	11.8±8.8	10.6±9.6

* 𝑃<0.05 versus week 0 of experimental group.
** 𝑃<0.01 versus week 0 of experimental group.
^#𝑃<0.05 versus week 4 of control group.
^##𝑃<0.01 versus week 4 of control group.